BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bell D, Hanna EY. Sinonasal undifferentiated carcinoma: morphological heterogeneity, diagnosis, management and biological markers. Expert Rev Anticancer Ther 2013;13:285-96. [PMID: 23477516 DOI: 10.1586/era.13.1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 de Souza LL, Morais TML, Pontes HAR, de Almeida OP, de Carvalho MGF, Soares CD. Rapidly ulcerated swelling in the hard palate of a HIV-positive pregnant woman. Oral Surg Oral Med Oral Pathol Oral Radiol 2021;131:e59-64. [PMID: 32063512 DOI: 10.1016/j.oooo.2019.12.026] [Reference Citation Analysis]
2 Mody MD, Saba NF. Multimodal Therapy for Sinonasal Malignancies: Updates and Review of Current Treatment. Curr Treat Options Oncol 2020;21:4. [PMID: 31950286 DOI: 10.1007/s11864-019-0696-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Lehrich BM, Goshtasbi K, Abiri A, Yasaka T, Sahyouni R, Papagiannopoulos P, Tajudeen BA, Kuan EC. Impact of induction chemotherapy and socioeconomics on sinonasal undifferentiated carcinoma survival. Int Forum Allergy Rhinol 2020;10:679-88. [PMID: 32104985 DOI: 10.1002/alr.22536] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Bell D, Hanna EY, Weber RS, DeMonte F, Triantafyllou A, Lewis JS Jr, Cardesa A, Slootweg PJ, Stenman G, Gnepp DR, Devaney KO, Rodrigo JP, Rinaldo A, Wenig BM, Westra WH, Bishop JA, Hellquist H, Hunt JL, Kusafuka K, Perez-Ordoñez B, Williams MD, Takes RP, Ferlito A. Neuroendocrine neoplasms of the sinonasal region. Head Neck 2016;38 Suppl 1:E2259-66. [PMID: 26041714 DOI: 10.1002/hed.24152] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 5.4] [Reference Citation Analysis]
5 Ylagan LR. Cytologic mimics of non-Hodgkin lymphoma in the head and neck. Seminars in Diagnostic Pathology 2015;32:296-304. [DOI: 10.1053/j.semdp.2014.12.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Tyler MA, Holmes B, Patel ZM. Oncologic management of sinonasal undifferentiated carcinoma. Current Opinion in Otolaryngology & Head & Neck Surgery 2019;27:59-66. [DOI: 10.1097/moo.0000000000000513] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
7 Taggart MW, Hanna EY, Gidley P, Weber RS, Bell D. Achaete-scute homolog 1 expression closely correlates with endocrine phenotype and degree of differentiation in sinonasal neuroendocrine tumors. Ann Diagn Pathol 2015;19:154-6. [PMID: 25892663 DOI: 10.1016/j.anndiagpath.2015.03.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
8 Bell D. Sinonasal Neuroendocrine Neoplasms: Current Challenges and Advances in Diagnosis and Treatment, with a Focus on Olfactory Neuroblastoma. Head Neck Pathol 2018;12:22-30. [PMID: 29427030 DOI: 10.1007/s12105-018-0887-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
9 Castelnuovo P, Turri-Zanoni M, Battaglia P, Antognoni P, Bossi P, Locatelli D. Sinonasal Malignancies of Anterior Skull Base: Histology-driven Treatment Strategies. Otolaryngol Clin North Am 2016;49:183-200. [PMID: 26614837 DOI: 10.1016/j.otc.2015.09.012] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 9.3] [Reference Citation Analysis]
10 Bell D, Hanna EY, Agaimy A, Weissferdt A. Reappraisal of sinonasal undifferentiated carcinoma: SMARCB1 (INI1)-deficient sinonasal carcinoma: a single-institution experience. Virchows Arch 2015;467:649-56. [DOI: 10.1007/s00428-015-1853-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
11 Bell D, Saade R, Roberts D, Ow TJ, Kupferman M, DeMonte F, Hanna EY. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol 2015;9:51-9. [PMID: 24806334 DOI: 10.1007/s12105-014-0547-3] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 8.9] [Reference Citation Analysis]
12 van Koevering K, Prevedello DM, Carrau RL. Endoscopic endonasal approaches for the management of cranial base malignancies: histologically guided treatment and clinical outcomes. J Neurosurg Sci 2018;62:667-81. [PMID: 29808637 DOI: 10.23736/S0390-5616.18.04507-1] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 López F, Lund VJ, Suárez C, Snyderman CH, Saba NF, Robbins KT, Vander Poorten V, Strojan P, Mendenhall WM, Rinaldo A, Ferlito A. The Impact of Histologic Phenotype in the Treatment of Sinonasal Cancer. Adv Ther 2017;34:2181-98. [PMID: 28871554 DOI: 10.1007/s12325-017-0605-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
14 Abdelmeguid AS, Bell D, Hanna EY. Sinonasal Undifferentiated Carcinoma. Curr Oncol Rep 2019;21:26. [PMID: 30806835 DOI: 10.1007/s11912-019-0776-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
15 Czapiewski P, Kunc M, Haybaeck J. Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment. Oncotarget 2016;7:52584-96. [PMID: 27256979 DOI: 10.18632/oncotarget.9683] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
16 Thompson LD. Small round blue cell tumors of the sinonasal tract: a differential diagnosis approach. Mod Pathol 2017;30:S1-S26. [PMID: 28060373 DOI: 10.1038/modpathol.2016.119] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
17 Bell D, Bell A, Ferrarotto R, Glisson B, Takahashi Y, Fuller G, Weber R, Hanna E. High-grade sinonasal carcinomas and surveillance of differential expression in immune related transcriptome. Ann Diagn Pathol 2020;49:151622. [PMID: 32927372 DOI: 10.1016/j.anndiagpath.2020.151622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Sommer F. Rare Diseases of the Nose, the Paranasal Sinuses, and the Anterior Skull Base. Laryngorhinootologie 2021;100:S1-S44. [PMID: 34352902 DOI: 10.1055/a-1331-2469] [Reference Citation Analysis]
19 Vaziri Fard E, Zhang S, Cai Z, Ding J, Sun Q, Saluja K, Zhu H. Sinonasal undifferentiated carcinoma: clinicopathological spectrums and diagnosis reappraisal. Human Pathology 2019;89:62-70. [DOI: 10.1016/j.humpath.2019.04.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
20 Guilmette J, Sadow PM. High-Grade Sinonasal Carcinoma: Classification Through Molecular Profiling. Arch Pathol Lab Med 2019;143:1416-9. [PMID: 30779592 DOI: 10.5858/arpa.2018-0224-RS] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
21 Spirin DS, Chernov IV, Cherekaev VA, Kalinin PL, Nazarov VV, Muzyshev IA, Absalyamova OV, Kobyakov GL, Vetlova ER. [Treatment of primary craniofacial (sinonasal) malignant tumors affecting the anterior and middle skull base]. Zh Vopr Neirokhir Im N N Burdenko 2020;84:101-8. [PMID: 32207749 DOI: 10.17116/neiro202084011101] [Reference Citation Analysis]
22 Saade RE, Hanna EY, Bell D. Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system. Curr Oncol Rep 2015;17:423. [PMID: 25416317 DOI: 10.1007/s11912-014-0423-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
23 Zeng Q, Tian Y, He Y, Xie Q, Ou L, Wang M, Chen W, Wei R. Long-Term Survival Outcomes and Treatment Experience of 64 Patients With Esthesioneuroblastoma. Front Oncol 2021;11:624960. [PMID: 33747939 DOI: 10.3389/fonc.2021.624960] [Reference Citation Analysis]